Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder

NCT00235508 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia
Generalized Anxiety Disorder

Interventions

DRUG: Eszopiclone (Lunesta)

Sponsor

Sumitomo Pharma America, Inc.